Author: Vandergrift M. Kanavos P.
Publisher: Elsevier
ISSN: 0168-8510
Source: Health Policy, Vol.41, Iss.3, 1997-09, pp. : 241-260
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The politics of health sector reform in developing countries: three cases of pharmaceutical policy
By Reich M.R.
Health Policy, Vol. 32, Iss. 1, 1995-04 ,pp. :
Health sector reform and the interpretation of policy context
By Collins C. Green A. Hunter D.
Health Policy, Vol. 47, Iss. 1, 1999-04 ,pp. :
Public attitude and knowledge on a new health policy for pharmaceutical care in Korea
By Kang H.-Y. Park C.Y. Joong Kim H.
Health Policy, Vol. 62, Iss. 2, 2002-11 ,pp. :
The new pharmaceutical policy in Italy
Health Policy, Vol. 46, Iss. 1, 1998-10 ,pp. :
Environmental health metanarratives: an analysis of policy making in Ontario, Canada
Health and Place, Vol. 5, Iss. 2, 1999-06 ,pp. :